The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study.

DIR MRI double inversion recovery multiple sclerosis white matter

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
12 Apr 2021
Historique:
received: 06 03 2021
revised: 08 04 2021
accepted: 09 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Using a white-matter selective double inversion recovery sequence (WM-DIR) that suppresses both grey matter (GM) and cerebrospinal fluid (CSF) signals, some white matter (WM) lesions appear surrounded by a dark rim. These dark rim lesions (DRLs) seem to be specific for multiple sclerosis (MS). They could be of great usefulness in clinical practice, proving to increase the MRI diagnostic criteria specificity. The aims of this study are the identification of DRLs on 1.5 T MRI, the exploration of the relationship between DRLs and disease course, the characterization of DRLs with respect to perilesional normal-appearing WM using magnetization transfer imaging, and the investigation of possible differences in the underlying tissue properties by assessing WM-DIR images obtained at 3.0 T MRI. DRLs are frequent in primary progressive MS (PPMS) patients. Amongst relapsing-remitting MS (RRMS) patients, DRLs are associated with a high risk of the disease worsening and secondary progressive MS (SPMS) conversion after 15 years. The mean magnetization transfer ratio (MTR) of DRLs is significantly different from the lesion without the dark rim, suggesting that DRLs correspond to more destructive lesions.

Identifiants

pubmed: 33921278
pii: diagnostics11040686
doi: 10.3390/diagnostics11040686
pmc: PMC8069390
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Radiology. 1986 Aug;160(2):543-7
pubmed: 3014600
Brain. 2015 May;138(Pt 5):1239-46
pubmed: 25823475
Ann Neurol. 2005 Dec;58(6):840-6
pubmed: 16283615
Acta Neuropathol. 2017 Jan;133(1):25-42
pubmed: 27796537
Magn Reson Med. 1998 Nov;40(5):749-53
pubmed: 9797159
Neuroimage. 2018 Nov 15;182:128-135
pubmed: 29208570
Lancet Neurol. 2019 Feb;18(2):198-210
pubmed: 30663609
Br J Radiol. 1994 Dec;67(804):1258-63
pubmed: 7874427
Ann Neurol. 2013 Dec;74(6):848-61
pubmed: 23868451
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
Neurology. 2013 Nov 12;81(20):1759-67
pubmed: 24122185
Mult Scler. 2014 Feb;20(2):214-9
pubmed: 23877971
Brain. 2012 Oct;135(Pt 10):2952-61
pubmed: 23065788
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
JAMA Neurol. 2019 Dec 1;76(12):1474-1483
pubmed: 31403674
Neurology. 2011 Feb 1;76(5):418-24
pubmed: 21209373
Acta Neuropathol. 2018 Apr;135(4):511-528
pubmed: 29441412
Acta Neuropathol. 2017 Jan;133(1):13-24
pubmed: 27988845
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
Ann Neurol. 2011 Nov;70(5):764-73
pubmed: 22162059
NMR Biomed. 2001 Apr;14(2):57-64
pubmed: 11320533
Ann Neurol. 2016 Oct;80(4):499-510
pubmed: 27464262
Neurology. 1983 Nov;33(11):1444-52
pubmed: 6685237
Arch Neurol. 2007 Oct;64(10):1416-22
pubmed: 17923625
Brain. 2019 Jan 1;142(1):133-145
pubmed: 30561514
N Engl J Med. 2018 Jan 11;378(2):169-180
pubmed: 29320652
J Nucl Med. 2014 Jul;55(7):1112-8
pubmed: 24904112
AJNR Am J Neuroradiol. 2018 Jun;39(6):1052-1058
pubmed: 29700044
Lancet Neurol. 2010 May;9(5):520-32
pubmed: 20398859

Auteurs

Francesco Crescenzo (F)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.
Neurology Unit, Mater Salutis Hospital, Legnago, 37045 Verona, Italy.

Damiano Marastoni (D)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Anna Isabella Pisani (AI)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Agnese Tamanti (A)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Caterina Dapor (C)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Annalisa Colombi (A)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Alessandro Brillo (A)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Roberta Magliozzi (R)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Francesca Benedetta Pizzini (FB)

Department of Diagnostics and Public Health, University of Verona, 37134 Verona, Italy.

Marco Castellaro (M)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Massimiliano Calabrese (M)

Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37134 Verona, Italy.

Classifications MeSH